TSE:MBX Microbix Biosystems (MBX) Stock Price, News & Analysis → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free MBX Stock Alerts C$0.32 -0.02 (-5.80%) (As of 04/26/2024 ET) Add Compare Share Share Today's RangeC$0.32▼C$0.3450-Day RangeC$0.34▼C$0.4152-Week RangeC$0.23▼C$0.47Volume166,766 shsAverage Volume71,155 shsMarket CapitalizationC$44.38 millionP/E Ratio10.83Dividend Yield2.30%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Get Microbix Biosystems alerts: Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About Microbix Biosystems Stock (TSE:MBX)Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.Read More MBX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MBX Stock News HeadlinesApril 25, 2024 | markets.businessinsider.comMicrobix Collaborator Introduces New Lab Accreditation ProgramApril 11, 2024 | finance.yahoo.comMicrobix Presenting at the 2024 Bloom Burton ConferenceApril 27, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…April 1, 2024 | finance.yahoo.comMicrobix Announces Annual and Special Meeting Voting ResultsMarch 14, 2024 | finance.yahoo.comMicrobix’s Clot-Buster Drug Project AdvancesMarch 11, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Unveils Test Controls for Head and Neck CancerMarch 11, 2024 | ca.finance.yahoo.comStocks in play: Microbix Biosystems Inc.March 1, 2024 | wsj.comMicrobix Biosystems Inc.April 27, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…February 26, 2024 | finance.yahoo.comMicrobix Announces Issuance of Stock OptionsFebruary 17, 2024 | finance.yahoo.comMicrobix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023)February 14, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Reports Record Results for Q1 Fiscal 2024February 14, 2024 | finance.yahoo.comMicrobix Reports Record Results for Q1 Fiscal 2024February 7, 2024 | finance.yahoo.comMicrobix Schedules Release of Results for Q1 Fiscal 2024February 6, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Unveils Test Control for Gastric Ulcer Disease PathogenFebruary 6, 2024 | finance.yahoo.comMicrobix Unveils Test Control for Gastric Ulcer Disease PathogenJanuary 3, 2024 | finance.yahoo.comMicrobix Achieves Further QAPs Sales RecordDecember 22, 2023 | finance.yahoo.comMicrobix Biosystems Full Year 2023 Earnings: Revenues Miss ExpectationsDecember 21, 2023 | finance.yahoo.comMicrobix Reports Results for Q4 & Full-Year Fiscal 2023December 14, 2023 | finance.yahoo.comMicrobix & Seegene USA Jointly Enhancing Lab Test AccuracyDecember 7, 2023 | finance.yahoo.comMicrobix & BioGX Collaborate on real-time PCR Assays & ControlsNovember 17, 2023 | financialpost.comMicrobix Presenting at Florida Capital Event ConferenceNovember 16, 2023 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Clot-Buster Drug Fully-Funded For Return to U.S. MarketNovember 16, 2023 | finance.yahoo.comMicrobix Clot-Buster Drug Fully-Funded For Return to U.S. MarketNovember 10, 2023 | finance.yahoo.comMicrobix & Ulisse Biomed Collaborate on HPV Controls & AssaysOctober 27, 2023 | finance.yahoo.comMicrobix QAPs Supporting HPV Testing in IrelandOctober 21, 2023 | investing.comMicrobix Biosystems Inc. (MBX)See More Headlines Receive MBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/14/2024Today4/26/2024Next Earnings (Estimated)5/09/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:MBX CUSIPN/A CIKN/A Webmicrobix.com Phone+1-905-3618910FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.03 Trailing P/E Ratio10.83 Forward P/E Ratio16.23 P/E GrowthN/ANet IncomeC$3.72 million Net Margins16.57% Pretax MarginN/A Return on Equity14.66% Return on Assets1.87% Debt Debt-to-Equity Ratio24.53 Current Ratio8.53 Quick Ratio5.57 Sales & Book Value Annual SalesC$22.42 million Price / Sales1.98 Cash FlowC$0.08 per share Price / Cash Flow4.13 Book ValueC$0.20 per share Price / Book1.63Miscellaneous Outstanding Shares136,550,000Free FloatN/AMarket CapC$44.38 million OptionableNot Optionable Beta0.28 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Cameron L. GroomePresident, CEO & DirectorMr. James S. CurrieChief Financial OfficerDr. Kenneth Hughes Ph.D.Chief Operating OfficerDr. Mark Luscher Ph.D.Senior Vice President of Scientific AffairsMr. Philip CasselliSenior Vice President of Sales, Business Development & MarketingMr. Christopher B. LobbCompliance Officer, General Counsel & SecretaryMore ExecutivesKey CompetitorsHelix BioPharmaTSE:HBPBriaCell TherapeuticsTSE:BCTSmall PharmaCVE:DMTProMIS NeurosciencesTSE:PMNEmerald Health TherapeuticsCVE:EMHView All CompetitorsInsidersBo HollasSold 100,000 sharesTotal: C$39,250.00 ($0.39/share)Steven Trevor HagermanSold 5,500 sharesTotal: C$2,172.50 ($0.40/share)Cameron Lionel GroomeSold 119,500 sharesTotal: C$47,023.25 ($0.39/share)Jennifer Anne StewartBought 13,945 shares on 1/22/2024Total: C$5,996.35 ($0.43/share)View All Insider Transactions MBX Stock Analysis - Frequently Asked Questions Should I buy or sell Microbix Biosystems stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MBX shares. View MBX analyst ratings or view top-rated stocks. How have MBX shares performed in 2024? Microbix Biosystems' stock was trading at C$0.39 at the beginning of 2024. Since then, MBX shares have decreased by 16.7% and is now trading at C$0.33. View the best growth stocks for 2024 here. When is Microbix Biosystems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our MBX earnings forecast. How were Microbix Biosystems' earnings last quarter? Microbix Biosystems Inc. (TSE:MBX) issued its quarterly earnings data on Wednesday, February, 14th. The company reported $0.02 earnings per share for the quarter. The firm earned $8.41 million during the quarter, compared to the consensus estimate of $8.10 million. Microbix Biosystems had a trailing twelve-month return on equity of 14.66% and a net margin of 16.57%. What other stocks do shareholders of Microbix Biosystems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), Organigram (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB). How do I buy shares of Microbix Biosystems? Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:MBX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
